Page last updated: 2024-11-02

pentoxifylline and Bile Duct Diseases

pentoxifylline has been researched along with Bile Duct Diseases in 1 studies

Bile Duct Diseases: Diseases in any part of the ductal system of the BILIARY TRACT from the smallest BILE CANALICULI to the largest COMMON BILE DUCT.

Research Excerpts

ExcerptRelevanceReference
"In this study pentoxifylline did not protect against post-ERCP pancreatitis or hyperamylasemia."9.12A randomized controlled trial of pentoxifylline for the prevention of post-ERCP pancreatitis. ( Christodoulou, D; Dimakopoulos, K; Kapetanos, D; Kitis, G; Kokozidis, G; Mistakidis, K; Sigounas, D; Tsianos, EV, 2007)
"In this study pentoxifylline did not protect against post-ERCP pancreatitis or hyperamylasemia."5.12A randomized controlled trial of pentoxifylline for the prevention of post-ERCP pancreatitis. ( Christodoulou, D; Dimakopoulos, K; Kapetanos, D; Kitis, G; Kokozidis, G; Mistakidis, K; Sigounas, D; Tsianos, EV, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kapetanos, D1
Kokozidis, G1
Christodoulou, D1
Mistakidis, K1
Sigounas, D1
Dimakopoulos, K1
Kitis, G1
Tsianos, EV1

Trials

1 trial available for pentoxifylline and Bile Duct Diseases

ArticleYear
A randomized controlled trial of pentoxifylline for the prevention of post-ERCP pancreatitis.
    Gastrointestinal endoscopy, 2007, Volume: 66, Issue:3

    Topics: Aged; Bile Duct Diseases; Cholangiopancreatography, Endoscopic Retrograde; Female; Humans; Hyperamyl

2007